STLN · Starling Oncology, Inc.

$6.54 +0.14 (+2.19%)

Market Cap

$652.26M

101.92M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-06	—
10-Q	2026-08-06	2026-06-30
8-K	2026-08-03	2026-07-28
8-K	2026-07-07	2026-07-01
8-K	2026-06-18	2026-06-17
8-K	2026-05-22	2026-05-20
8-K	2026-05-07	—
10-Q	2026-05-07	2026-03-31
DEF 14A	2026-04-30	2026-06-17
8-K	2026-03-13	—
8-K	2026-03-12	—
10-K	2026-03-12	2025-12-31
8-K	2026-02-23	—
8-K	2026-01-12	—
8-K	2026-01-07	2026-01-02
8-K	2025-12-01	2025-11-26
8-K	2025-11-14	—
10-Q	2025-11-13	2025-09-30
8-K	2025-11-13	—
8-K	2025-11-06	2025-11-03
10-Q	2025-08-13	2025-06-30
8-K	2025-08-13	—
8-K	2025-08-13	2025-08-08
8-K	2025-05-19	—
8-K	2025-05-14	—
10-Q	2025-05-14	2025-03-31
8-K	2025-05-08	2025-05-07
8-K	2025-05-07	2025-05-02
8-K	2025-04-11	2025-04-09
DEF 14A	2025-03-27	2025-05-07
8-K	2025-03-27	2025-03-26
10-K	2025-03-26	2024-12-31
8-K	2025-03-25	2025-03-24
8-K	2025-03-24	—
8-K	2025-03-24	—
8-K	2025-02-26	—
8-K	2024-12-19	—
8-K	2024-11-13	—
10-Q	2024-11-13	2024-09-30
8-K	2024-11-12	2024-11-08
8-K	2024-09-23	2024-09-19
10-Q	2024-08-13	2024-06-30
8-K	2024-08-13	—
8-K	2024-06-21	2024-06-20
8-K	2024-06-13	—
10-K/A	2024-05-22	2023-12-31
10-Q/A	2024-05-22	2024-03-31
10-Q	2024-05-14	2024-03-31
8-K	2024-05-14	—
DEF 14A	2024-05-02	2024-06-13

Showing 1–50 of 118 filings

Key facts CIK 1799191 CUSIP 68236X100 13F (30d) 128 filings 128 filers Visit website Investor relations